Hepatology Xagena

Xagena Mappa
Medical Meeting

Search results for "Sebivo"

The phase III GLOBE trial for Telbivudine ( Sebivo, Tyzeka ) successfully reached its primary, composite efficacy endpoint of therapeutic response at one year in chronic hepatitis B patients. This e ...

A study has revealed that virological breakthrough is common in patients receiving nucleoside analogs ( NUCs ) for chronic hepatitis B. Nearly 40% of the virological breakthrough found were not relate ...